Leukemia News and Research

RSS

Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.

New whole body positron emission tomography (PET) imaging allows scientists to watch as immune system respond to tumors or infection

Compared to the snapshot views of the immune system from tumor biopsies or blood assays, this whole body imaging allows scientists to track how the immune response changes, and the tumor or infection responds, throughout the different phases of immune response and over long periods of time.

15 Jun 2004

John Kerry pushes for new cures and treatments for Alzheimer’s

Drawing on the inspiration of Nancy Reagan and millions of families who bravely comfort suffering loved ones, Democratic Presidential candidate John Kerry Saturday said we must lift the barriers that stand in the way of science to find new cures and treatments for Alzheimer’s and other diseases through stem cell research.

14 Jun 2004

Common weeds may be better than herbal cousins for preventing and curing a host of diseases

Unwanted, pulled or poisoned, the lowly weed is sometimes better than its highly touted “herbal” cousins for preventing and curing a host of diseases, according to University of Florida research.

10 Jun 2004

America's first two WNV encephalitis cases of 2004 respond to treatment

GenoMed, Inc. has announced that the country's second case of West Nile virus encephalitis has responded promptly to its treatment approach. So far, GenoMed's treatment is showing a 100% response rate among 13 immunocompetent patients. The sooner the treatment is instituted, the more rapid and more complete the response.

10 Jun 2004

New drugs ease treatment of multiple myeloma

Science is increasingly commuting the death sentence that is a diagnosis of multiple myeloma. A cancer of the plasma cells that primarily strikes the elderly, multiple myeloma has been deadly because patients have been unable to withstand the aggressive treatment necessary to combat it.

10 Jun 2004

Only half of gemcitabine dose may be activated in cancer patients

The study, presented in a poster discussion session by Jason Fisher, a student at the University of Pittsburgh School of Engineering, analyzed data from 31 cancer patients given 30-minute infusions of gemcitabine to determine what percentage of the drug dose was associated with concentrations that exceeded the body's ability to activate the drug.

9 Jun 2004

New statistical techniques for cancer diagnosis

CSIRO statisticians have developed a new way to subtype paediatric Acute Lymphoblastic Leukaemia (ALL), the most common form of cancer in children under 12.

9 Jun 2004

SU11248 proves effective in the treatment of gastrointestinal stromal tumors

A drug originally developed to block the formation of blood vessels in tumors has been shown to overcome resistance to treatment with Gleevec in patients with gastrointestinal stromal tumors (GIST).

9 Jun 2004

Elderly leukemia patients benefit from intensive treatment

Contrary to popular belief, patients over the age of 75 with acute myelogenous leukemia (AML) do just as well as younger patients with similar chemotherapy regimens. A new study published June 7, 2004 in the online edition of CANCER

7 Jun 2004

A biological agent used without chemotherapy appears to offer a disease-free future to patients with rare leukemia

A biological agent — a drug that wraps vitamin A inside bubbles of fat — used without chemotherapy appears to offer as many as one-third of patients with a rare form of leukemia an opportunity for a long-term, disease-free future, say researchers at The University of Texas M. D. Anderson Cancer Center.

7 Jun 2004

Research seeks best mix of hope and care for leukaemia sufferers

Funding has been granted for research seeking the best care options for patients with leukaemia and other blood disorders and their families.

5 Jun 2004

Drug Tarceva improves survival chance for patients with advanced lung cancer

Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).

5 Jun 2004

Cancer rates falling in the US

The nation's leading cancer organizations report that Americans' risk of getting and dying from cancer continues to decline and survival rates for many cancers continue to improve.

3 Jun 2004

Umbilical cord blood and bone marrow transplants slow the progression of many cancers

Umbilical cord blood and bone marrow transplants at Loyola University Health System, Maywood, Ill., are curing or slowing the progression of many cancers originating in the bone marrow (i.e., leukemia, myeloma) or lymphatic system (lymphoma).

3 Jun 2004

Higher rate of cancer in meat industry

A study of over 6600 meat industry workers around New Zealand has found a significantly high rate of cancers, particularly lung cancer, which may be caused by exposure to cancer causing agents carried by animals.

31 May 2004

Women exposed in adulthood to cytomegalovirus may be at greater risk of breast cancer

A study just published in the prestigious British Journal of Cancer by researchers at the University of Otago's Christchurch School of Medicine and Health Sciences and Dunedin School of Medicine, and the University of Melbourne, has found evidence of a link between a common virus and breast cancer in women under the age of 40 years.

31 May 2004

Smoking a lot more harmful than previously thought

The U.S. Surgeon General has released a new comprehensive report on smoking and health, revealing for the first time that smoking causes diseases in nearly every organ of the body. Published 40 years after the surgeon general's first report on smoking -- which concluded that smoking was a definite cause of three serious diseases -- this newest report finds that cigarette smoking is conclusively linked to diseases such as leukemia, cataracts, pneumonia and cancers of the cervix, kidney, pancreas and stomach.

30 May 2004

Leukemia News and Research

Further Reading

New whole body positron emission tomography (PET) imaging allows scientists to watch as immune system respond to tumors or infection

John Kerry pushes for new cures and treatments for Alzheimer’s

Common weeds may be better than herbal cousins for preventing and curing a host of diseases

America's first two WNV encephalitis cases of 2004 respond to treatment

New drugs ease treatment of multiple myeloma

Only half of gemcitabine dose may be activated in cancer patients

New statistical techniques for cancer diagnosis

SU11248 proves effective in the treatment of gastrointestinal stromal tumors

Elderly leukemia patients benefit from intensive treatment

A biological agent used without chemotherapy appears to offer a disease-free future to patients with rare leukemia

Research seeks best mix of hope and care for leukaemia sufferers

Drug Tarceva improves survival chance for patients with advanced lung cancer

Cancer rates falling in the US

Umbilical cord blood and bone marrow transplants slow the progression of many cancers

Higher rate of cancer in meat industry

Women exposed in adulthood to cytomegalovirus may be at greater risk of breast cancer

Smoking a lot more harmful than previously thought

Smoking causes diseases in nearly every organ of the body

Cigarette smoking linked to leukemia

Speakers will predict the future of where the field of cancer diagnosis and treatment is going in the next ten years

Michael Stryker

The past, present and future of automation and digitalization in the life sciences laboratory

Arxspan BioDrive: A Versatile Solution for Molecular Biology

Latest News